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AP-1-Controlled Hepatocyte Growth Factor
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Peter Schirmacher1, Axel Szabowski3,4 and Kai Breuhahn1,4
Keratinocyte migration is essential for the rapid closure of the epidermis in the process of wound healing.
Mesenchymal cell-derived hepatocyte growth factor (HGF) is a central regulator of this process. However, the
molecular mechanisms and relevant genes that facilitate this cellular response are still poorly defined. We used
heterologous cocultures combining primary human keratinocytes and genetically modified murine fibroblasts
to identify key factors mediating HGF-induced epidermal cell migration. The absence of c-Jun activity in
fibroblasts completely abolished the expression of HGF in these cells and consequently altered the behavior of
keratinocytes. Time-resolved expression series of keratinocytes stimulated with HGF disclosed target genes
regulating HGF-dependent motility. In addition to well-established HGF-dependent wound healing-associated
genes, carcinoembryogenic antigen-related cell adhesion molecule (CEACAM)-1 and the urokinase plasmino-
gen activator (uPA)/uPA-receptor (uPAR) pathway were identified as possible mediators in HGF-induced
keratinocyte migration. The functional relevance of CEACAM-1 and uPA/uPAR on epidermal cell motility was
demonstrated using the HaCaT cell culture model. In conclusion, the distinct spatiotemporal regulation of
genes by HGF is essential for proper epidermal cell migration in cutaneous wound healing.
Journal of Investigative Dermatology (2009) 129, 1140–1148; doi:10.1038/jid.2008.350; published online 20 November 2008
INTRODUCTION
The healing of skin wounds represents a paradigm for
eukaryotic regeneration. This highly complex process in-
cludes migration, proliferation, and differentiation of various
cell types. The balance and order of these cellular responses
is coordinated and fine tuned by a plethora of secreted
soluble factors such as growth factors, cytokines, and
chemokines. Increasing evidence suggest that transforming
growth factor (TGF)-b, granulocyte-macrophage colony-
stimulating factor (GM-CSF), keratinocyte growth factor
(KGF), and epidermal growth factor receptor (EGF-R)-
mediated signaling are critically involved in proper cuta-
neous wound healing (Werner et al., 1994; Mann et al.,
2001; Amendt et al., 2002; Shirakata et al., 2005). These
soluble factors exhibit partially overlapping as well as
specific biological activities on distinct cell populations of
the skin (Werner and Grose, 2003).
To distinguish among the biological effects of growth
factors on certain cell populations during regeneration as
well as under pathophysiological conditions, it is necessary
to dissect this process into its functional subunits. Sources of
paracrine-acting soluble factors are mainly inflammatory
cells as well as dermal fibroblasts (Martin, 1997). However,
studies applying organotypic skin equivalents clearly demon-
strated that inflammatory cells modulate keratinocyte beha-
vior, but they are not central for proper re-epithelialization
(Bell et al., 1981). In contrast, fibroblast-derived growth
factors dramatically alter the response of keratinocytes in
coculture model systems (Szabowski et al., 2000).
In skin, hepatocyte growth factor (HGF) is derived from
mesenchymal cells and stimulates epidermal keratinocytes in
a paracrine manner via activation of the membrane-bound
tyrosine kinase MET, which is specifically expressed in motile
keratinocytes of the leading edge (Chmielowiec et al., 2007).
Promotion of regeneration by HGF/MET signaling has been
demonstrated by topical application of HGF and gene
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transfer in murine models (Nakanishi et al., 2002; Yoshida
et al., 2004). Human chronic skin ulcers exhibit decreased
HGF expression, whereas HGF application supports
re-epithelialization by increasing keratinocyte proliferation
and migration (Nayeri et al., 2002, 2005). However, a
comprehensive and time-resolved analysis of the HGF-
response required for the understanding of the complete
mechanism of HGF-induced keratinocyte biofunctionality is
missing. This approach has to consider the presence of
transcripts derived from other cell types as well as from
nonresponding keratinocytes, which might conceal specific
gene regulation (Cole et al., 2001). In contrast, expression
analyses derived from in vitro monocultures in a restricted
manner reflect the natural cytokine microenvironment of
multicellular tissues. To solve these problems and to under-
stand the time-dependent-specific effects of HGF on epider-
mal keratinocytes, we used heterologous cocultures
combining primary human keratinocytes and murine c-jun/
fibroblasts (Szabowski et al., 2000). In this model, deficiency
of the AP-1 transcription factor constituent c-Jun disturbs the
IL1a/b-dependent double paracrine epidermal/dermal feed-
back loop, leading to a deprivation of fibroblast-derived
growth factors such as KGF and GM-CSF. Although the
expression of secreted factors with biological functions partly
overlapping those of HGF is missing in this coculture model,
an appropriate balance between proliferation and differentia-
tion of keratinocytes is maintained. This basal activity of
keratinocytes is most likely based on unknown AP-1-
independent and fibroblast-derived secreted factors or on
cell/cell contact between keratinocytes and fibroblasts.
By using heterologous coculture, we show that c-Jun-
deficiency abolished HGF expression in fibroblasts. There-
fore, this system allowed the specific identification of HGF-
target genes possibly involved in keratinocyte migration after
HGF stimulation in a time-dependent manner with very low
background. The stimulation of primary human keratinocytes
and subsequent time-resolved large-scale expression profiling
leads to the identification of carcinoembryogenic antigen-
related cell adhesion molecule (CEACAM)-1 and the uroki-
nase plasminogen activator (uPA)/uPA-receptor (uPAR) sys-
tem as potential factors for the initiation and maintenance of
HGF-dependent epidermal cell migration. The functional
relevance of both factors was experimentally verified using
immortalized but nontumorigenic HaCaT cells.
RESULTS AND DISCUSSION
c-Jun-dependent HGF expression of fibroblasts affects
keratinocyte morphology
The loss of the AP-1 constituent c-Jun in murine fibroblasts
abolishes the expression of factors affecting keratinocyte
behavior such as KGF, GM-CSF, pleiotrophin, and stromal
cell-derived factor-1 (Szabowski et al., 2000; Florin et al.,
2005). As the effects of a lack of c-Jun activity on HGF
expression were unknown, we analyzed the relative HGF
transcript levels in c-Jun-deficient fibroblasts compared to
those in their wild-type counterparts. HGF expression was
nearly completely absent at the transcript level (499%) in
c-Jun knockout fibroblasts (Figure 1a), thus showing an
expression behavior in these cells comparable to GM-CSF
(Figure 1b).
Hepatocyte growth factor, similar to GM-CSF, is able to
stimulate proliferation of keratinocytes (Breuhahn et al.,
2000; Bevan et al., 2004). In addition, HGF induces a
migratory response, whereas GM-CSF modulates the differ-
entiation of keratinocytes in particular (Braunstein et al.,
1994). We therefore tested whether supplementation of
cocultures containing primary human keratinocytes and
murine c-Jun-deficient fibroblasts with recombinant HGF or
GM-CSF reestablished the proliferative response. Both growth
factors restored keratinocyte proliferation, but they also lead
to clear morphological differences. Keratinocytes cocultured
with wild-type fibroblasts formed large and round colonies of
uniform vital cells (Figure 1c). Cocultures of keratinocytes
with c-Jun-deficient fibroblasts gave rise to small colonies
with a high proportion of stratifying cells (Figure 1d). The
supplementation of HGF (Figure 1e) or GM-CSF (Figure 1f)
into the culture media of cocultures with c-Jun-deficient
fibroblasts restored island size and the number of vital
keratinocytes, indicating a reestablished proliferative re-
sponse. After adding GM-CSF, the cellular morphology and
colony shape of keratinocytes was reminiscent of the
phenotype observed in coculture with wild-type fibroblasts
(Figure 1c and Figure 1f). HGF-treated keratinocytes ap-
peared to be larger and less coherent (Figure 1e), demonstrat-
ing that the morphology of epithelial cells was independent
of the proliferative response. These data verify that HGF is an
AP-1 target in fibroblasts and that HGF contributes to but
does not completely cover keratinocyte biofunctionality.
Importantly, the heterologous coculture model combining
human and murine cells provided an excellent tool to identify
unique HGF-target genes in human keratinocytes.
Identification of exclusive HGF-target genes modulating
keratinocyte migration
To identify HGF-specific mediators at the transcriptional level
in primary human keratinocytes in a time-dependent manner,
large-scale oligonucleotide expression profiling was per-
formed. Keratinocytes in cocultures containing c-Jun-defi-
cient fibroblasts, which expressed neither HGF nor GM-CSF,
were stimulated with recombinant human HGF or GM-CSF at
different time points (keratinocyte donor 1: 0, 1, 2, 4, and
8 hours). HGF and GM-CSF stimulation was monitored by
measuring vascular endothelial growth factor and IL-18
induction using semiquantitative real-time PCR for RNA
samples that were subjected to microarray analyses (data not
shown). A comparison of HGF- and GM-CSF-induced genes
after expression profiling demonstrated that most of the HGF-
dependent targets responded specifically to HGF alone but
not to GM-CSF. To analyze the unique HGF-response in
keratinocytes all GM-CSF-regulated genes were withdrawn
from the HGF-target gene list.
On oligonucleotide-microarray chips not all probe sets for
a particular gene may give rise to similar expression values.
Possible reasons for this phenomenon include splice variants
and various distances to the 30-prime end of mRNA. To
increase the specificity of our analysis, probe sets were
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inspected carefully and nonresponding probe sets of HGF
targets were excluded from further analysis. From all probe
sets on the arrays, the expression levels of nonregulated probe
sets (98.1%) showed an induction of 1.0 with an average
amplitude of 0.2. Overall, 252 probe sets (1.1%) coding for
177 different genes exhibited a statistically significant
induction (factor X1.5) within the experimental time frame
of 8 hours (Table S1), whereas 183 probe sets (0.8%),
representing 138 different genes showed a statistically
significant reduction (factor X1.5; Table S2).
To exclude keratinocyte donor-specific effects, primary
human keratinocytes from a second donor were stimulated in
parallel (keratinocyte donor 2: 3 hours). Besides large-scale
expression profiling, the expression of selected HGF-induced
transcripts such as connective tissue growth factor (CTGF),
TNF-a-induced protein 3, matrix-metalloproteinase 10
(MMP-10), uPA, uPAR as well as involucrin as a negative
control confirmed the results obtained by donor 1 (Figure 2a–f).
We then analyzed protein levels of genes that were
specifically regulated at the RNA level by HGF but not by
GM-CSF treatment. We selected uPAR and MMP-10 that
have previously not been described in the context of HGF-
induced keratinocyte migration but that are essential reg-
ulators for the motile phenotype in other cell types. Only
HGF-treatment lead to elevated concentrations of MMP-10
and uPAR in protein extracts derived from primary keratino-
cytes cocultured with c-Jun-deficient fibroblasts (Figure 3a
and b). These data illustrate the reliability and reproducibility
of the heterologous coculture approach for the specific
identification of HGF-target genes.
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Figure 1. Fibroblast-derived HGF contributes to proliferation and colony architecture of keratinocytes in the heterologous coculture. Relative transcript
levels of HGF (a) and GM-CSF (b) in murine wild-type (wt) and c-Jun-deficient fibroblasts were determined by real-time PCR 3 days after seeding. Wt fibroblasts
served as calibrator. Primary human keratinocytes were cocultured with wt (c) and c-Jun-deficient (d) fibroblasts in the absence or presence of HGF (e) and
GM-CSF (f). Colony formation was digitally documented 5 days after cytokine application. Representative colony margins are indicated by dashed lines.
Magnification:  200, scale bar¼ 100mm.
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To address the chronology of induced and repressed
genes, we analyzed expression courses of all genes that were
modulated by HGF treatment. Most induced genes exhibited
an early expression maximum (o4 hours), whereas only
few induced genes showed a late expression maximum
(44 hours) or a continuously increased transcript level. In
contrast, few repressed genes exhibited early minima or
continuously reduced expression, whereas most transcripts
presented late minima (Table 1). Therefore, a biphasic
expression pattern of HGF-target genes was observed,
suggesting that most induced genes may represent direct
responses, whereas most suppressed genes are likely to
represent secondary responses.
Importantly, many induced genes have previously been
shown to be expressed in keratinocytes (44.6%), which
further supports the reliability of this approach in identifying
previously unreported HGF targets (Table 2). Equally,
numerous genes have been described to be regulated by
HGF or in the context of cutaneous wound healing. Only four
induced genes (MMP-1, MMP-9, neuregulin-1, and vascular
endothelial growth factor (VEGF)) were known from the
context of HGF-dependent wound healing or regeneration.
To obtain further insight into the functional role of these
genes during HGF-regulated processes, we grouped the
identified induced genes according to their specific func-
tional assignments (Tables S1 and S2). As HGF is one of the
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Figure 2. Confirmation of HGF-induced-target gene expression in primary
keratinocytes. To exclude keratinocyte donor-dependent effects on target
gene expression, results generated by large-scale microarray analyses (donor
1) were confirmed with independently isolated keratinocytes cocultured with
c-Jun-deficient fibroblasts and stimulated with HGF or GM-CSF (donor 2:
3 hours after treatment). Microarray-derived expression kinetic (donor 1) and
real-time PCR (donor 2) for CTGF (a), TNFAIP3 (b), MMP-10 (c), uPA (d),
uPAR (e), and involucrin (f, negative control) are depicted. Wild-type (wt)
fibroblasts were used for calibration. Multiple graphs for donor 1 represent
independent probe sets.
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Figure 3. Confirmation of HGF-induced protein expression of uPAR and
MMP-10 in primary keratinocytes. At 6 hours after HGF and GM-CSF
stimulation human keratinocytes cocultured with c-Jun-deficient fibroblasts
were collected by differential trypsination. Total protein fractions were
isolated and subjected to Western blot analyses using anti-MMP-10 (a) and
anti-uPAR (b) antibodies.
Table 1. Summary of identified expression profiles for
HGF-specific target genes in keratinocytes
Peak description Induced genes (%) Repressed genes (%)
o4 h 60.5 10.8
44 h 13.5 75.4
Continuous 26.0 13.8
Table 2. Summary of all HGF target genes that have
been described in the literature
Described in context with
Induced genes
(%)
Repressed genes
(%)
Keratinocytes 44.6 12.3
Wound healing 24.9 5.8
HGF stimulation 20.3 4.3
HGF stimulation in wound
healing
2.3 0
HGF, hepatocyte growth factor.
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most potent inducers of migration, it is not surprising to find
many genes primarily involved in cell adhesion and motility
(20.3%). These included MMPs, laminin 5 subunits, and
junction proteins. Only a small number of genes primarily
involved in proliferation or apoptosis were identified.
Interestingly, several secreted factors (20.9%) were detected
after HGF stimulation including cytokines and growth factors,
hormones, and chemokines. Especially in the group of
cytokines and growth factors, numerous well-known proteins
essential for proper regulation of regeneration were found
such as VEGF, transforming growth factor (TGF)-a, epiregu-
lin, neuregulin-1, and heparin-binding epidermal growth-like
factor (HB-EGF).
On the basis of strong selection criteria and the back-
ground-free experimental setup, these data clearly suggest
that the set of identified genes mediated the HGF-specific
motogenic response of keratinocytes. Unexpectedly, the
identified genes responding to HGF stimulation did not
represent sets of genes directly modulating proliferation,
although HGF application also restored the number of vital
keratinocytes (Figure 1f). As HGF-dependent activation of a
motile phenotype is obviously the most dominant effect in
keratinocytes, one has to ask how the induction of prolifera-
tion is mediated in our coculture system and in other in vivo
models (Bevan et al., 2004). In this context, we identified
several secreted factors that explain many described auto-
and paracrine effects. Although VEGF, CTGF, and IL-8 are
known regulators of neovascularization, fibroblast prolifera-
tion, and immunomodulation (Engelhardt et al., 1998;
Toyoda et al., 2001; Brigstock, 2002), elevated expression
of TGF-a, epiregulin, and uPA might explain the observed
effects on keratinocyte proliferation (Jensen and Lavker,
1996; Shirakata et al., 2000; Maas-Szabowski et al., 2003).
In addition, most of these secreted factors exhibit their own
strong migration-promoting effects on keratinocytes, which
further amplify and sustain cell motility in a (secondary) HGF-
dependent manner (Li et al., 2006). Therefore, the time-
dependent expression of target genes by keratinocytes after
HGF stimulation is probably responsible for the direct
induction of cell migration, the maintenance of cell motility
as well as the initiation of proliferation.
HGF-dependent induction of uPA/uPAR-pathway constituents
involved in migration
To understand the potential of HGF to fine tune the activity of
signaling pathways in keratinocytes during regeneration, we
grouped induced genes according to their annotation. Genes
belonging to three distinct pathways became apparent: the
uPA/uPAR pathway, the prostaglandin pathway, and the IL-1
pathway (Tables S1 and S2). As uPA/uPAR signaling has been
described to induce cell migration (Jensen and Lavker, 1996)
and uPA and uPAR were both identified as HGF targets by
our screen, we asked whether the activity of this pathway
may contribute to the induction and maintenance of HGF-
mediated motility in epidermal cells.
Both uPA and uPAR were induced in HGF-stimulated
primary human keratinocytes cocultured with c-Jun-deficient
fibroblasts; however, they exhibited different expression
kinetics and magnitudes (Figure 2d: continuous increase of
uPA; Figure 2e: early peak for uPAR). In murine full-thickness
wounds, HGF-transcript levels were already strongly elevated
only 2 days after wounding, whereas uPA and uPAR showed
NS
++
HGF GM-CSF
−−
∗
1.2
1.0
0.8
0.6
0.4
0.2
0
2.5
2.0
1.5
1.0
0.5
uPA
uPA
Actin Actin
+HGF +GM
-CSF
uPAR
uPAR 
7,000
6,000
5,000
4,000
3,000
2,000
1,000
HGF
Untreated +HGF +GM
-CSFUntreated
Skin Day 1 Day 2 Day 5 Day 7
Post-wounding
R
el
at
ive
 m
ig
ra
tio
n
Anti-uPAR antibody
R
el
at
ive
 u
PA
ex
pr
es
sio
n
R
el
at
ive
 u
PA
R
ex
pr
es
sio
n
R
el
at
ive
 H
G
F
ex
pr
es
sio
n
3,000
2,500
2,000
1,500
1,000
500
Skin Day 1 Day 2 Day 5 Day 7
Post-wounding
Skin Day 1 Day 2 Day 5 Day 7
Post-wounding
stimulation
Figure 4. HGF-induced uPA/uPAR signaling enhances migration of keratinocytes. Analysis of HGF (a), uPA (b), and uPAR (c) expression in murine
skin after full-thickness wounding (normal skin, 1, 2, 5, and 7 days) by real-time PCR. (d) HaCaT cells were stimulated with HGF and GM-CSF for 6 hours.
The expression of uPA and uPAR was determined by Western immunoblots. (e) Migration assays performed after HGF and GM-CSF stimulation and application
of anti-uPAR neutralizing antibodies. P-values were determined by Mann–Whitney U-test; *Po0.05.
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a long lasting induction (Florin et al., 2006; Figure 4a–c).
Because the analyses of migration are highly challenging in
this experimental coculture setup (for example, heterologous
cell conditions ranging from differentiated to mitotic cells,
highly sensitive to slight temperature and spatial variations),
we decided to examine HaCaT cells, which stem from a
spontaneously transformed and immortalized but nontumori-
genic epidermal cell line derived from primary human skin
keratinocyte cultures (Boukamp et al., 1988). HaCaT cells are
closely approximated to keratinocytes and offer a suitable
model for the study of HGF-dependent effects on epidermal
cell motility (Boukamp et al., 1988). Both uPA and uPAR
were exclusively induced in HaCaT cells by HGF but not by
GM-CSF stimulation (Figure 4d). Efficient reduction of uPA/
uPAR signaling using inhibitory antibodies specific for uPAR
significantly reduced HGF-induced cell migration but did not
exert effects after GM-CSF stimulation (Figure 4e).
The effects of the uPA/uPAR system on cell motility are to
a major extent mediated through proteolysis of, for example,
extracellular matrix and plasminogen (Ploug, 2003). More-
over, based on a high degree of structural homology in the
cleavage site between pro-HGF and plasminogen, uPA
directly activates pro-HGF proteolytically (Naldini et al.,
1992). Thus, the HGF-dependent induction of uPA is of
special interest for the maintenance of HGF bioavailability
and the HGF-dependent motile phenotype. In our experi-
mental keratinocyte/fibroblast coculture setup, inactive pro-
HGF does not exist because c-Jun-deficient fibroblasts do not
express HGF. Therefore, the profound contribution of uPA on
epidermal cell migration is not readily explained by
continuous de novo production of bioactive HGF. Further-
more, plasminogen activator inhibitor (PAI)-1 is induced by
HGF and is able to temporary block the enzymatic activity of
uPA (Andreasen et al., 1986). Therefore, it is very likely that
in addition to proteolytic cleavage of plasminogen and
subsequent activation of the serine protease plasmin, the
contribution of uPA to HGF-induced migration is partly
mediated via activation of its respective receptor uPAR and
modulation of signal transduction (Kjoller, 2002). It is also of
special interest that several genes functionally interacting
with the uPA/uPAR pathway were identified in our screen.
For example, the IL-6 signal transducer/gp130, integrins, and
PAI-1 physically interact with uPAR and uPA and might
further fine tune proteolytic activity and signaling of uPA/
uPAR after HGF stimulation.
Surprisingly, skin wound healing was only marginally
impaired in uPA-deficient mice, whereas the combined
ablation of uPA and tissue-type plasminogen activator (tPA)
resulted in a significantly delayed wound closure (Bugge
et al., 1996; Lund et al., 2006). These results strongly suggest
the functional redundancy of uPA and tPA in the context of
cutaneous regeneration. Because HGF stimulation of human
keratinocytes elevated the expression of both uPA and tPA in
our experimental setup with different kinetics (continuous vs
early expression profile), a central inductor function of
fibroblast-derived HGF for full-motile competence of kerati-
nocytes can be assumed (Table S1). This conclusion is
supported by the fact that uPA, tPA, and uPAR have been
detected in the keratinocyte leading edge, where the HGF
receptor MET is predominantly localized in the process of
regeneration (unpublished own data; Romer et al., 1991,
1994; Chmielowiec et al., 2007; Lian et al., 2008).
CEACAM1 expression is essential for HGF-induced migration
To substantiate the inductor function of HGF on epithelial
cell motility, we decided to analyze a new potential effector
of HGF-induced migration. On the basis of our selection
criteria for this gene, namely (1) previously unknown in the
context of cutaneous wound healing, (2) impact on cell
adhesion, and (3) interaction with essential cytoplasmic
signaling constituents (for example, kinases), we selected
CEACAM1(syn. CD66, biliary glycoprotein 1) among the list
of HGF targets. CEACAM1 is expressed by endothelial and
epithelial cells (Brummer et al., 1995; Prall et al., 1996) and
is involved in proliferation, morphogenesis, and migration of
different cell types under physiological and pathophysiologi-
cal conditions (Busch et al., 2002; Klaile et al., 2005; Muller
et al., 2005).
First, we confirmed rapid CEACAM1 induction in primary
keratinocytes cocultured with c-Jun-deficient fibroblasts after
HGF stimulation by real-time PCR (Figure 5a and b). As MET
is strongly expressed in motile human keratinocytes of the
leading edge under wound healing conditions (Chmielowiec
et al., 2007), we asked whether CEACAM1 is detectable in
this area. Using immunohistochemistry, no significant stain-
ing for CEACAM1 was observed in normal, unwounded skin,
although a specific staining was detected in epidermal cells
in wounded skin (Figure 5c).
To further analyze, the relevance of CEACAM1 in the
context of HGF-induced migration in epidermal cells we
performed analyses using immortalized HaCaT cells. In these
cells CEACAM1 protein levels rapidly increased only 1 h after
HGF-treatment and then decreased after 8 hours (Figure 5d).
It is noteworthy that the time-dependent expression of
CEACAM1 in HaCaT cells reflected the kinetics observed in
human keratinocytes after single dose HGF application
(Figure 5a and b), again suggesting the comparability of both
model systems with respect to the expression of HGF-target
genes and subsequent induction of migration. To test for the
functional relevance of CEACAM1 for HGF-induced motility,
CEACAM1 expression was inhibited in HaCaT cells using
transcript-specific small-interfering RNAs (siRNAs). A nearly
complete inhibition was observed after transfection of
independent CEACAM1 siRNAs compared to controls (Figure
5e). Subsequently, we performed two-dimensional ‘‘scratch’’-
migration assays using HGF-stimulated HaCaT cells with and
without CEACAM1 inhibition. Indeed, the siRNA-mediated
reduction of CEACAM1 expression completely abolished
HGF effects on HaCaT migration (Figure 5f). Thus, CEACAM1
is a new essential mediator of HGF-induced epidermal cell
motility. With regard to CEACAM1 effects on migration of
epithelial cells, it is of interest that interactions with distinct
binding partners such as filamin A modulate its pro- or anti-
migratory effects (Klaile et al., 2005). The binding of filamin A
with CEACAM1 significantly reduced migration and scatter-
ing. Indeed, a reduction of filamin A in the epidermis near the
www.jidonline.org 1145
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wound edge was described (Kubler and Watt, 1993),
suggesting that HGF-induced CEACAM1 expression and the
integration of additional para- or autocrine stimuli respon-
sible for filamin A reduction are essential for CEACAM1-
dependent keratinocyte migration during regeneration.
HGF/MET signaling is essential for proper skin wound
healing and in this regard, no other signaling axis can
functionally compensate for a loss of the HGF/MET pathway
(Chmielowiec et al., 2007). Exploiting the absolute AP-1
dependency of HGF-expression in an organotypic keratino-
cyte coculture model, we have now defined the unique HGF
response in human keratinocytes that is largely responsible
for the migratory phenotype in the immortalized keratino-
cyte-derived HaCaT cell line. This response includes the
activation of the uPA/uPAR pathway and CEACAM1; how-
ever, additional HGF targets not analyzed in detail in this
study are probably involved in the HGF-dependent motile
phenotype.
MATERIALS AND METHODS
Cell culture and transfection
The organotypic coculture consisting of normal human skin
keratinocytes (one skin sample for each experimental series) and
wild-type as well as c-Jun-deficient mouse fibroblasts have been
described previously (Maas-Szabowski et al., 2001). The study was
approved by the institutional ethics committee (application no. 206/
05) of the Medical Faculty at Heidelberg University. For the initial
experiments, FAD medium (DMEM:Hams (4:1); 10% FCS) with or
without cytokines (HGF and GM-CSF; 10 ng/ml; R&D Systems,
Wiesbaden, Germany) was replaced every 2 days. After 5 days
(before formation of a continuous cell layer), cellular and colony
morphology was digitally documented. For expression profiling,
total RNA of human keratinocytes was isolated 0, 1, 2, 4, and 8 hours
after cytokine treatment. Selective trypsination and harvesting of
human keratinocytes have been described previously (Szabowski
et al., 2000). Immortalized HaCaT cells were cultured with DMEM
(10% FCS, 100U/ml penicillin, 100mg/ml streptomycin). Before
cytokine treatment (HGF and GM-CSF; 10 ng/ml), cells were
incubated in serum-free medium for 24 hours. Proteins were isolated
at indicated time points after cytokine supplementation.
All siRNA transfection assays for gene-specific inhibition were
performed using Oligofectamine (Invitrogen, Karlsruhe, Germany)
according to the standard protocol. Sequences of siRNAs used in this
study are listed in Table S3.
Real-time PCR and Western blot analyses
Sample preparations of total RNA for semiquantitative real-time
PCR, protein isolations for Western blot analyses, and densitometric
quantification were performed as described previously (Singer et al.,
2007). Primer sequences used in this study are listed in Table S3. All
primers were tested for species specificity (data not shown).
Experimental samples were matched to a standard curve using
serially diluted cDNA samples.
Primary antibodies used in this study were: anti-human uPAR
(0.1 mg/ml; R&D Systems), anti-human uPA (1mg/ml; R&D Systems),
anti-human MMP-10 (0.2 mg/ml; R&D Systems), anti-human
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Figure 5. HGF-induced CEACAM1 expression modulates migration of keratinocytes. Time-resolved expression patterns of CEACAM1 in primary human
keratinocytes cocultured with murine c-Jun-deficient fibroblasts after HGF-treatment determined by (a) microarray analysis and by (b) real-time PCR. (c)
Immunohistochemical analyses of CEACAM1 in normal and wounded human epidermis. Note staining in epidermis of wounded skin while no signal was
detected in unwounded skin. Magnification:  200, scale bar¼ 50mm. (d) Analysis of time-dependent CEACAM1 expression in HaCaT cells after HGF
stimulation (10 ng/ml) by Western immunoblot. (e) CEACAM1-specific siRNAs (C#1, C#2) reduced target gene expression compared to nonsense siRNAs (N#1,
N#2) in HaCaT cells. (f) Efficient inhibition of CEACAM1 lead to a complete loss of HGF-induced cell migration as compared to nonsense siRNA-treated
controls. P-values were determined by Mann-Whitney U; ***Po0.001.
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phospho-AKT (pS[473], 1:1000; Invitrogen), anti-human AKT
(1:1000; Cell Signaling Technology, Frankfurt, Germany), anti-
human CEACAM1 (0.2mg/ml; R&D Systems), and anti-human actin
(0.01mg/ml; MP-Biomedicals, Aurora, OH, USA). Antibodies were
diluted in Tris-buffered saline Tween-20 (5% milk powder) and
incubated at 4 1C overnight. After three washes in Tris-buffered
saline Tween-20 for 10minutes each, the appropriate secondary
antibody was applied (1:2000; HRP-anti-mouse and HRP-anti-
rabbit) at room temperature for 1 hour, followed by three washes
in Tris-buffered saline Tween-20. The ECL plus system (Amersham
Bioscience, Freiburg, Germany) was applied for signal detection.
Migration assay
Migration assays were performed as described previously (Singer
et al., 2007). Cells were treated with cytokines (HGF or GM-CSF;
10 ng/ml) or neutralizing antibodies for uPAR (1.2mg/ml) and
incubated for 18 hours. Migration assays after CEACAM1 inhibition
were performed 3 days after transfection of siRNAs. Relative
migratory activity was measured by calculating cell-free areas.
Expression profiling and data analyses
Total mRNA samples for microarray measurements were obtained
from donor 1 after 0, 1, 2, 4, and 8 hours (donor 2: 3 hours). Total
RNAs were isolated, labeled, and hybridized to HG-U133-plus 2.0
(Affymetrix) according to the manufacturers’ protocol. Raw micro-
array data were processed using the R environment (http://www.
r-project.org) and the Bioconductor toolbox (http://www.
bio-conductor.org). Normalization was performed using the var-
iance stabilization algorithm available in the Bioconductor package
vsn (Huber et al., 2002). Quality of the results was assessed using the
made4 R package for the multivariate analysis of gene expression
data (Culhane et al., 2005). The subsequent probe annotation was
handled with a Bioconductor package annaffy. Expression changes
were calculated with respect to the corresponding mean expression
levels of two control measurements in uninduced cocultures at 0 and
8hours. Microarray data are available through the ArrayExpress
homepage: http://www.ebi.ac.uk/arrayexpress/genes/any/E-TABM-440.
Software
The data were submitted to statistical analyses using SPSS (SPSS
Software, Munich, Germany). Cell-free area determination was
performed using an analysis soft imaging system (Olympus,
Hamburg, Germany). Functional assignments of genes were
performed using the GeneCards database (Weizmann Institute of
Science, Rehovot, Israel) and PubMed literature search (NCBI,
Bethesda, MD). Search parameters were (gene abbreviation):kerati-
nocyte(s), :skin, :wound, :HGF).
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